Mirati Therapeutics MRTX
$ 58.7
0.0%
Quarterly report 2023-Q3
added 11-06-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Charles Baum |
Employees in the company |
111 |
Shares |
56.2 M |
Market Cap[1] |
$ 3.3 B |
EBITDA (LTM) |
$ -736 M |
P/E (LTM) |
-3.35 |
P/S (LTM) |
53.83 |
EPS (LTM) |
-11.8 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.